ArticleFrontiers in endocrinology2026
Development and validation of a nomogram model integrating noninvasive detection of radial pulse wave for predicting diabetic foot risk in type 2 diabetes mellitus.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to develop and evaluate a nomogram model based on Traditional Chinese Medicine (TCM) pulse mapping parameters to predict the risk of diabetic foot (DF) in patients with type 2 diabetes mellitus (T2DM). Methods: A retrospective analysis was performed on clinical data and pulse mapping parameters from 485 T2DM patients hospitalized in the Departments of Vascular Diseases and Endocrinology at Shanghai TCM-Integrated Hospital between July 26, 2023, and April 9, 2025. Patients were divided into a DF group ( Results: Gender (OR = 0.501, Conclusion: This nomogram model provides an individualized and visualized tool for predicting DF risk in T2DM patients, offering TCM-based reference indicators for early DF risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.